CLINICAL_TRIALS
trial_result
· 2022-08-29
Clinical Trial Update: A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis [Phase 3]
Summary
Phase 3 trial update on Ampion for osteoarthritis of the knee; study completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ampio Pharmaceuticals. Inc. | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2022-08-29